Filing Details
- Accession Number:
- 0000741815-16-000092
- Form Type:
- 13D Filing
- Publication Date:
- 2016-04-06 16:05:53
- Filed By:
- Hooper Holmes Inc
- Company:
- 200 Nnh Llc
- Filing Date:
- 2016-04-06
- SEC Url:
- 13D Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| 10,000,000 | 0 | 10,000,000 | 011 | 10,000,000 | 7.9% |
Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
WASHINGTON, DC 20549
SCHEDULE 13D
(Amendment No. ____)*
Hooper Holmes Inc.
(Name of Issuer)
Common Stock, par value $0.04 per share
(Title of Class of Securities)
439 104 100
(CUSIP Number)
Henry Dubois
Chief Executive Officer
Hooper Holmes Inc.
560 N. Rogers Road
Olathe, KS 66062
(913) 764-1045
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
With Copies To:
Peter Mirakian III
Spencer Fane LLP
1000 Walnut Street, Suite 1400
Kansas City, MO 64106
(816) 474-8100
March 28, 2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
CUSIP No: 439 104 100
1. | NAME OF REPORTING PERSON: |
200 NNH, LLC
IRS Identification Number of above reporting person: 90-0971908
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(See Instructions):
(a) [ ]
(b) [ ]
3. SEC USE ONLY
4. | SOURCE OF FUNDS (See Instructions) WC |
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e): [ ]
6. | CITIZENSHIP OR PLACE OF ORGANIZATION USA |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7. | SOLE VOTING POWER | 10,000,000 |
8. | SHARED VOTING POWER | 0 | |
9. | SOLE DISPOSITIVE POWER | 10,000,000 | |
10. | SHARED DISPOSITIVE POWER | 0 | |
11. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,000,000 |
12. | CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] |
13. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.9% |
14. | TYPE OF REPORTING PERSON (See Instructions) OO |
Pursuant to the terms of the Stock Purchase Agreement, for so long as the Purchaser owns at least 5% of the outstanding Common Stock of the Issuer, the Purchaser will have the right to appoint a representative to attend meetings of the Issuer’s Board of Directors in a nonvoting observer capacity and to receive copies of all notices, minutes, consents and other materials provided to directors of the Issuer.
Item 5. Interest in Securities of the Issuer.
(a) The Purchaser may be deemed to beneficially own 10,000,000 shares of Common Stock. Such ownership represents 7.9% of the issued and outstanding shares of the Issuer.
(b) Number of shares as to which the Purchaser has:
(i) sole power to vote or to direct the vote: 10,000,000
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the disposition of: 10,000,000
(iv) shared power to dispose or direct the disposition of: 0
(c) None of the Purchaser itself nor any of the persons named on Schedule I related to the Purchaser has effected any transactions in securities of the Issuer during the last 60 days.
(d)-(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
Pursuant to the terms of the Stock Purchase Agreement, the Purchaser is restricted from selling the Purchased Shares without the Issuer’s prior written consent for a period of 18 months following the date of the Stock Purchase Agreement. Pursuant to the terms of the Stock Purchase Agreement, for so long as the Purchaser owns at least 5% of the outstanding Common Stock of the Issuer, the Purchaser will have the right to appoint a representative to attend meetings of the Issuer’s Board of Directors in a nonvoting observer capacity and to receive copies of all notices, minutes, consents and other materials provided to directors of the Issuer.
Item 7. Material to be Filed as Exhibits.
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: April 6, 2016 200 NNH, LLC
By:/s/ J. Vartan Hovsepian
J. Vartan Hovsepian, Managing Director
Schedule I
Name | Citizenship | Business or Residence Address | Present Principal Occupation or Employment | Name and Address of Corporation or other Organization in Which Such Occupation or Employment is Conducted |
Avedis Tavitian, M.D. | United States | 801 S. Chevy Chase Dr., #30, Glendale, CA 91205 | Principal | Kanon Ventures, 801 S. Chevy Chase Dr., #30, Glendale, CA 91205 |
Ara Tavitian, M.D. | United States | 801 S. Chevy Chase Dr., #30, Glendale, CA 91205 | Principal | Kanon Ventures, 801 S. Chevy Chase Dr., #30, Glendale, CA 91205 |
J. Vartan Hovsepian | United States | 801 S. Chevy Chase Dr., #30, Glendale, CA 91205 | Managing Director | Kanon Ventures, 801 S. Chevy Chase Dr., #30, Glendale, CA 91205 |